US Drug Recall Register

FDA Drug Recalls

11,815 recalls · Class II, newest first

Class II · Moderate risk Terminated

fentaNYL

Reason Lack of Assurance of Sterility; product has the potential to leak.

SCA Pharmaceuticals NDC 70004-0202-40 D-1009-2017
Class II · Moderate risk Terminated

fentaNYL

Reason Lack of Assurance of Sterility; product has the potential to leak.

SCA Pharmaceuticals NDC 70004-0201-40 D-1008-2017
Class II · Moderate risk Terminated

BUPIVacaine HCl 0.1% PF

Reason Lack of Assurance of Sterility; product has the potential to leak.

SCA Pharmaceuticals NDC 70004-0060-40 D-1005-2017
Class II · Moderate risk Terminated

PHENYLephrine HCl 10 mg in 0.9% Sodium Chloride

Reason Lack of Assurance of Sterility: Product made with recalled 0.9% sodium chloride bags which have the potential to leak.

SCA Pharmaceuticals D-1004-2017
Class II · Moderate risk Terminated

Diltiazem 125 mg in 0.9% Sodium Chloride

Reason Lack of Assurance of Sterility: Product made with recalled 0.9% sodium chloride bags which have the potential to leak.

SCA Pharmaceuticals D-1002-2017
Class II · Moderate risk Terminated

ceFAZolin 3 g added to 100 mL 0.9% Sodium Chloride

Reason Lack of Assurance of Sterility: Product made with recalled 0.9% sodium chloride bags which have the potential to leak.

SCA Pharmaceuticals D-1001-2017
Class II · Moderate risk Terminated

fentaNYL

Reason Lack of Assurance of Sterility: Product made with recalled 0.9% sodium chloride bags which have the potential to leak.

SCA Pharmaceuticals D-1000-2017
Class II · Moderate risk Terminated

morphine sulfate 1 mg per mL in 0.9% Sodium Chloride

Reason Lack of Assurance of Sterility: Product made with recalled 0.9% sodium chloride bags which have the potential to leak.

SCA Pharmaceuticals D-0999-2017
Class II · Moderate risk Terminated

0.9% Sodium Chloride Injection

Reason Lack of Assurance of Sterility: Bags have the potential to leak.

Baxter Healthcare Corporation D-0973-2017
Class II · Moderate risk Terminated

5% Dextrose Injection

Reason Lack of Assurance of Sterility: Bags have the potential to leak.

Baxter Healthcare Corporation D-0972-2017
Class II · Moderate risk Terminated

0.9% Sodium Chloride Injection USP

Reason Lack of Assurance of Sterility: Customer complaints for leaking bags.

Baxter Healthcare Corporation NDC 0338-0049-02 D-0957-2017
Class II · Moderate risk Terminated

Carbamazepine Oral Suspension

Reason Labeling Error: Label mix-up. Products' unit dose cups are correctly labeled, but the product carton lists incorrect volume and NDC.

Precision Dose Inc. NDC 68094-301-59 D-1037-2017
Class II · Moderate risk Terminated

parodontax WHITENING

Reason Presence of Foreign Substance: possibility of the presence of metal in the product.

GSK Consumer Healthcare NDC 0135-0601-01 D-0944-2017
Class II · Moderate risk Terminated

Lactulose Solution

Reason Microbial contamination of non-sterile product: product failed Total Yeast/Mold Count specification.

VistaPharm, Inc. NDC 66689-038-01 D-1053-2017
Class II · Moderate risk Terminated

Lactulose Solution

Reason Microbial contamination of non-sterile product: product failed Total Yeast/Mold Count specification.

VistaPharm, Inc. NDC 66689-038-50 D-1052-2017
Class II · Moderate risk Terminated

Potassium PHOSphate in 5% Dextrose Injection

Reason Lack of Assurance of Sterility; media fill failure at manufacturer

PharMedium Services, Llc NDC 61553-300-11 D-0997-2017
Class II · Moderate risk Terminated

Potassium PHOSphate in 5% Dextrose Injection

Reason Lack of Assurance of Sterility; media fill failure at manufacturer

PharMedium Services, Llc NDC 61553-310-41 D-0995-2017